Search For "covid 19 vaccine"
WHO chief 'glad' to see Covaxin get WHO approval for emergency use
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], November 3 (ANI): Director-General of the World Health Organisation Tedros Adhanom Ghebreyesus on Wednesday said that he was glad to see Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin, get WHO approval for Emergency Use Listing (EUL).
Read More
WHO's Soumya Swaminathan congratulates India for Covaxin emergency nod
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], November 3 (ANI): WHO Chief Scientist Soumya Swaminathan on Wednesday congratulated India after the World Health Organisation (WHO) granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More
Jaishankar welcomes WHO's decision to grant Emergency Use Listing to Covax
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): External Affairs Minister Dr S Jaishankar on Wednesday welcomed the World Health Organisation (WHO)'s decision to grant approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More
Covaxin 'extremely suitable' for low, middle-income countries due to easy
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], November 3 (ANI): The World Health Organisation (WHO) has said that Covaxin -- COVID-19 vaccine developed by Bharata Biotech -- is extremely suitable for low and middle-income countries due to easy storage requirements.
Read More
Covaxin meets WHO standards for protection against COVID-19, says expert p
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], November 3 (ANI): The World Health Organization (WHO) has granted emergency use listing (EUL) for India's indigenous vaccine Covaxin, adding to a growing portfolio of vaccines validated by WHO for prevention of COVID-19.
Read More
Central Drugs Standard Control Organisation extends Covaxin shelf life to
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body.
Read More
WHO grants approval to Covaxin for emergency use listing
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], November 3 (ANI): The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.
Read More
There should be no laxity in ongoing COVID-19 vaccination drive: PM Modi
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): Prime Minister Narendra Modi on Wednesday emphasised on the need to maintain a good pace of COVID-19 vaccine administration and said that there should be no laxity in the ongoing vaccination drive.
Read More
More than 114 cr COVID-19 vaccine doses provided to states, UTs so far: Ce
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): More than 114 crore COVID-19 vaccine doses have been provided to states and union territories so far, out of which, more than 14.68 crore balance and unutilised doses are still available with them to be administered, informed the Ministry of Health and Fa
Read More
U'khand CM thanks residents for 100 pc first dose COVID vaccine coverage
Updated : 4 years, 8 months ago IST
Dehradun (Uttarakhand) [India], November 3 (ANI): Uttarakhand Chief Minister Pushkar Singh Dhami on Tuesday thanked the people of Uttarakhand and health workers as the state vaccinated 100 per cent of its eligible residents with the first dose of COVID-19 vaccine.
Read More
Over 107.29 cr COVID-19 vaccine doses administered in India
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): India has administered more than 107.29 crore COVID-19 vaccine doses so far, informed the Ministry of Health and Family Welfare on Wednesday.
Read More
US formally recommends Pfizer COVID-19 vaccine for children aged 5-11
Updated : 4 years, 8 months ago IST
Washington [US], November 3 (ANI): Following rigorous review and authorization process by the US Food and Drug Administration (FDA), the Centers for Disease Control (CDC) on Tuesday (local time) has formally recommended the Pfizer COVID-19 vaccine for children 5-11.
Read More